Haupt Pharma has completed a successful inspection by FDA at its site in Italy. The inspection covered all areas of the organization and systems involved in the production of sterile penicillin products. Following the seven-day audit, the site is now approved to produce two sterile penicillin antibiotics for the U.S. market. “We have reached an important milestone by successfully passing the FDA inspection in Latina, which confirms the high standards of good manufacturing practice at our comp...